406
Participants
Start Date
December 5, 2017
Primary Completion Date
January 29, 2020
Study Completion Date
September 7, 2020
efpeglenatide (SAR439977)
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"
placebo
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"
Investigational Site Number 2760005, Berlin
Investigational Site Number 8400008, Hatboro
Investigational Site Number 8040004, Vinnitsa
Investigational Site Number 8400028, Burlington
Investigational Site Number 8400031, Wilmington
Investigational Site Number 8400025, Lawrenceville
Investigational Site Number 8400010, DeLand
Investigational Site Number 8400006, Hialeah
Investigational Site Number 8400032, West Palm Beach
Investigational Site Number 8400004, Birmingham
Investigational Site Number 8400013, Maumee
Investigational Site Number 2760003, Frankfurt am Main
Investigational Site Number 8400034, Chicago
Investigational Site Number 8400033, Kansas City
Investigational Site Number 8400018, Lincoln
Investigational Site Number 8400017, Carrollton
Investigational Site Number 8400019, Plano
Investigational Site Number 8400030, Dallas
Investigational Site Number 8400015, Houston
Investigational Site Number 8400023, Schertz
Investigational Site Number 8400020, San Antonio
Investigational Site Number 8400016, San Antonio
Investigational Site Number 8400027, San Antonio
Investigational Site Number 8400005, Glendale
Investigational Site Number 8400062, Las Vegas
Investigational Site Number 8400021, Las Vegas
Investigational Site Number 8400009, Los Angeles
Investigational Site Number 8400003, Canoga Park
Investigational Site Number 8400024, Tarzana
Investigational Site Number 8400026, Van Nuys
Investigational Site Number 8400029, Pomona
Investigational Site Number 8400007, Chula Vista
Investigational Site Number 8400011, La Mesa
Investigational Site Number 8400001, Bridgeton
Investigational Site Number 8400002, Holladay
Investigational Site Number 2760001, Leipzig
Investigational Site Number 6160005, Gdansk
Investigational Site Number 6160004, Gdynia
Investigational Site Number 6160007, Katowice
Investigational Site Number 6160002, Krakow
Investigational Site Number 6160006, Poznan
Investigational Site Number 6160003, Warsaw
Investigational Site Number 6160001, Wroclaw
Investigational Site Number 8040003, Kyiv
Investigational Site Number 8040001, Kyiv
Investigational Site Number 8040002, Kyiv
Investigational Site Number 8260005, Birmingham
Investigational Site Number 8260004, Cardiff
Investigational Site Number 8260007, Chorley
Investigational Site Number 8260008, Glasgow
Investigational Site Number 8260001, Hexham
Investigational Site Number 8260003, Liverpool
Investigational Site Number 8260006, Manchester
Investigational Site Number 8260002, Reading
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Hanmi Pharmaceutical Company Limited
INDUSTRY